Patents by Inventor Mai YOSHIKAWA

Mai YOSHIKAWA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11925930
    Abstract: In an apparatus, a gas containing CH4 and CO2 is supplied from a first supply unit to a synthetic gas production unit which generates a synthetic gas containing CO and H2 while heating a first catalytic structure; the synthetic gas is supplied to a gas production unit which generates a lower olefin-containing gas including propylene while heating a second catalytic structure; and a detection unit detects propylene discharged from the gas production unit. The first catalytic structure includes first supports having a porous structure and a first metal fine particle that is present in first channels of the first supports. The second catalyst structure includes second supports having a porous structure and a second metal fine particle in the second supports. The second supports have a second channels, a portion of which have an average inner diameter of 0.95 nm or less.
    Type: Grant
    Filed: December 3, 2019
    Date of Patent: March 12, 2024
    Assignee: FURUKAWA ELECTRIC CO., LTD.
    Inventors: Yuichiro Banba, Kaori Sekine, Yukako Nakai, Mai Nishii, Masayuki Fukushima, Sadahiro Kato, Takao Masuda, Yuta Nakasaka, Takuya Yoshikawa
  • Patent number: 11643458
    Abstract: Objective of the present invention is to provide a novel monoclonal antibody against Nav1.7. The present invention discloses a monoclonal antibody against Nav1.7 or its antibody fragment, having specific six CDRs (CDR1 to CDR3 of a heavy chain and CDR1 to CDR3 of a light chain) or specific heavy/light chain variable regions. The monoclonal antibody and the like can be used for treating or preventing pain, pruritus and so on.
    Type: Grant
    Filed: May 30, 2019
    Date of Patent: May 9, 2023
    Assignee: SHIONOGI & CO., LTD.
    Inventors: Tatsuya Takahashi, Mai Yoshikawa, Sosuke Yoneda, Junji Onoda, Etsuo Nakamura, Tsuguo Miyauchi, Toshiyuki Asaki, Erika Kasai
  • Publication number: 20220064312
    Abstract: Disclosed is a novel anti-CCR8 antibody. The antibody can be used for treating or preventing cancers or the like.
    Type: Application
    Filed: December 27, 2019
    Publication date: March 3, 2022
    Applicants: Shionogi & Co., Ltd., Osaka University
    Inventors: Mai Yoshikawa, Tatsuya Takahashi, Junji Onoda, Sunao Imai, Etsuo Nakamura, Kentaro Furukawa, Tsuguo Miyauchi, Tetsuya Yoshida, Morio Nagira, Naganari Ohkura, Atsushi Tanaka, Shimon Sakaguchi, Hisashi Wada, Atsunari Kawashima
  • Publication number: 20210221876
    Abstract: Objective of the present invention is to provide a novel monoclonal antibody against Nav1.7. The present invention discloses a monoclonal antibody against Nav1.7 or its antibody fragment, having specific six CDRs (CDR1 to CDR3 of a heavy chain and CDR1 to CDR3 of a light chain) or specific heavy/light chain variable regions. The monoclonal antibody and the like can be used for treating or preventing pain, pruritus and so on.
    Type: Application
    Filed: May 30, 2019
    Publication date: July 22, 2021
    Applicant: SHIONOGI & CO., LTD.
    Inventors: Tatsuya TAKAHASHI, Mai YOSHIKAWA, Sosuke YONEDA, Junji ONODA, Etsuo NAKAMURA, Tsuguo MIYAUCHI, Toshiyuki ASAKI, Erika KASAI